Abstract
This prospective study evaluates emotional functioning and illness representations in 68 unaffected women (34 carriers/34 noncarriers) 1 year after predictive testing for BRCA1/2 mutations when offered within a multidisciplinary approach. Carriers had higher subjective risk perception of breast cancer than noncarriers. Carriers who did not have prophylactic oophorectomy had the highest risk perception of ovarian cancer. No differences were found between carriers and noncarriers regarding perceived seriousness and perceived control of breast and ovarian cancer. Mean levels of distress were within normal ranges. Only few women showed an overall pattern of clinically elevated distress. Cancer-specific distress and state-anxiety significantly decreased in noncarriers from pre- to posttest while general distress remained about the same. There were no significant changes in distress in the group of carriers except for ovarian cancer distress which significantly decreased from pre- to posttest. Our study did not reveal adverse effects of predictive testing when offered in the context of a multidisciplinary approach.
Similar content being viewed by others
References
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, A., Pasini, B., Radice, P., Manoukian, S., Heeles, D. M., Tang, M., Olah, E., Anton-Culver, H., Warner, E., Lubinski, J., Gronwald, J., Gorski, B., Tulinius, H., Thorlacius, S., Eerola, H., Nevanlinna, H., Syrjakoski, K., Kallioniemi, O.-P., Thomposn, D., Evans, C., Peto J., Lalloo, F., Evans, D. G., & Easton, D. F. (2003). Average risks of breast and ovarian cancer associated with BRCA1or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet, 72, 1117–1130.
Arrindell, W. A., & Ettema, J. H. M. (1986). SCL-90. Handleiding bij een multidimensionele psychopathologie-indicator. Lisse: Swets & Zeitlinger.
Audrain, J., Schwartz, M. D., Lerman, C., Hughes, C., & Peshkin, B. N. (1997). Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: The contributions of personality and appraisal. Ann Behav Med, 19, 370–377.
Bleiker, E. M. A., Hahn, D. E. E., & Aaronson, N. K. (2003). Psychosocial issues in cancer genetics. Current status and future directions. Acta Oncologica, 42, 276–286.
Broadstock, M., Michie, S., Gray, J., Mackay, J., & Marteau, T. M. (2000). The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer—A pilot study. Psychooncology, 9, 537–548.
Champion, V. L. (1984). Instrument development for health belief model constructs. Adv Nurs Sci, 6, 73–85.
Claes, E., Denayer, L., Evers-Kiebooms, G., Boogaerts, A., & Legius, E. (2004). Predictive testing for hereditary non-polyposis colorectal cancer: Motivation, illness representations and short-term psychological impact. Patient Educ Couns, 55, 265–274.
Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet, 116A, 11–19.
Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2004). Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: Women's looking back on the pretest period and a psychological evaluation. Genetic Test, 8, 13–21.
Claes, E., Evers-Kiebooms, G., Decruyenaere, M., Denayer, L., Boogaerts, A., Philippe, K., & Legius, E. (in press). Surveillance behavior and prophylaetic surgery after predictive testing for hereditary breast/ovarian cancer. Behav Med.
Codori, A. M., Petersen, G. M., Miglioretti, D. L., Larkin, E. K., Bushey, M. T., Young, C., Brensinger, J. D., Johnson, K., Bacon, J. A., & Booker, S. V. (1999). Attitudes toward colon cancer gene testing: Factors predicting uptake. Cancer Epidemiol Biomark Prev, 8, 345–351.
Coyne, J. C., Kruus, L., Racioppo, M., Calzone, K., & Armstrong, K. (2003). What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer. Am J Med Genet, 116A, 222–228.
Croyle, R. T., & Lerman, C. (1999). Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr, 25, 59–66.
Croyle, R. T., Smith, K. R., Botkin, J. R., Baty, B., & Nash, J. (1997). Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol, 16, 63–72.
De Vos, M., Poppe, B., Delvaux, I., Mortier, G., Claes, K., Messiaen, L., & De Paepe, A. (1999). Genetic counseling and testing for hereditary breast and ovarian cancer: The Gent(le) Approach. Dis Markers, 15, 191–195.
Decruyenaere, M., Evers-Kiebooms, G., Denayer, L., Welkenhuysen, M., Claes, E., Legius, E., & Demyttenaere, K. (2000). Predictive testing for hereditary breast and ovarian cancer: A psychological framework for pre-test counselling. Eur J Hum Genet, 8, 130–136.
Decruyenaere, M., Evers-Kiebooms, G., Welkenhuysen, M., Denayer, L., & Claes, E. (2000). Cognitive representations of breast cancer, emotional distress and preventive health behaviour: A theoretical perspective. Psychooncology, 9, 528–536.
Dekker, J., & Oomen, J. (1999). Depression and coping. Eur J Psychiatry, 13, 183–189.
Dorval, M., Patenaude, A. F., Schneider, K. A., Kieffer, S. A., DiGianni, L., Kalkbrenner, K. L., Bromberg, J. I., Basili, L.~A., Calzone, K., Stopfer, J., Weber, B. L., & Garber, J. E. (2000). Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs. J Clin Oncol, 18, 2135–2142.
DudokdeWit, A. C., Tibben, A., Duivenvoorden, H. J., Niermeijer, M. F., Passchier, J., Trijsburg, R. W., & the Rotterdam/Leiden Genetics Workgroup (1998). Distress individuals facing predictive DNA testing for Autosomal Dominant Late-Onset Disorders: Comparing Questionnaire results with in-depth interviews. Am J Med Genet, 75, 62–74.
Evers-Kiebooms, G. (1990). Predictive testing for Huntington's disease in Belgium. J Psychosom Obstet Gynaecol, 11, 61–72.
Evers-Kiebooms, G., Welkenhuysen, M., Claes, E., Decruyenaere, M., & Denayer, L. (2000). The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: Implications for multidisciplinary counselling and for genetic education. Soc Sci Med, 51, 831–841.
Folkman, S., & Lazarus, R. S. (1988). Coping as a mediator of emotion. J Pers Soc Psychol, 54, 466–475.
Hagger, M. S., & Orbell, S. (2003). A meta-analytic review of the common-sense model of illness representations. Psychol Health, 18, 141–184.
Horowitz, M. J., Wilner, N., & Alvarez, W. (1979). Impact of Event Scale: A measure of subjective stress. Psychosom Med, 41, 209–218.
Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal and coping. New York: Springer.
Lerman, C., & Croyle, R. T. (1996). Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology, 10, 191–195.
Lerman, C., Croyle, R. T., Tercyak, K. P., & Hamann, H. (2002). Genetic testing: Psychological aspects and limitations J Consult Clin Psychol, 70, 784–797.
Lerman, C., Hughes, C., Lemon, S. J., Main, D., Snyder, C., Durham, C., Narod, S., & Lynch, H. T. (1998). What you don't know can hurt you: Adverse psychological effects in members of BRCA1-linked and BRCA2-linked families who decline testing. J Clin Oncol, 16, 1650–1654.
Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S. J., Conway, T., Tonin, P., Lenoir, G., & Lynch, H. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA, 275, 1885–1892.
Lerman, C., Schwartz, M. D., Lin, T. H., Hughes, C., & Narod, S. (1997). The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol, 65, 414–420.
Lim, J., Macluran, M., Price, M., Bennett, B., Butow, P., and the kConFab Psychosocial group (2004). Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. J Genet Counsel, 13, 115–133.
Loader, S., Shields, C. G., & Rowley, P. T. (2004). Impact of genetic testing for breast-ovarian cancer susceptibility. Genet Test, 8, 1–12.
Lodder, L. N. (2001). Dealing with the risk for hereditary breast and ovarian cancer. A prospective study on psychological consequences of choices on genetic testing, surveillance and prophylactic surgery. Erasmus University Rotterdam, Doctoral dissertation.
Lodder, L. N., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G., Seynaeve, C., van Geel, A. N., Tilanus, M. M., Bartels, C. C., Verhoog, L. C., Brekelmans, C. T., Burger, C. W., & Niermeijer, M. F. (2002). One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Ther, 73, 97–112.
Lodder, L. N., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G., Duivenvoorden, H. J., Tibben, A., Wagner, A., van der Meer, C. A., van den Ouweland, A. M., & Niermeijer, M. F. (2000). The psychological impact of receiving BRCA1/BRCA2 test results. Am J Med Genet, 98, 15–24.
Meiser, B., & Halliday, J. L. (2002). What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med, 54, 1463–1470.
Meiser, B., Butow, P., Friedlander, M., Barratt, A., Schnieden, V., Watson, M., Brown, J., & Tucker, K. (2002). Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer, 38, 2025–2031.
Pasacreta, J. V. (2003). Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: An integrative review. Cancer Invest, 21, 588–623.
Scharloo, M., Kaptein, A. A., Weinman, J., Hazes, J. M., Willems, L. N. A., Bergman, W., & Rooijmans, H. G. M. (1998). Illness perceptions, coping and functiong in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res, 44, 573–585.
Schreurs, P. J., van de Willige, G., Tellegen, B., & Brosschot, J. F. (1988). De Utrechtse Copinglijst. Omgaan met problemen en gebeurtenissen. Lisse: Swets & Zeitlinger.
Schwartz, M. D., Peshkin, B. N., Hughes, C., Main, D., Isaacs, C., & Lerman, C. (2002). Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol, 20, 514–520.
Shapiro, D. H., Schwartz, C. E., & Astin, J. A. (1996). Controlling ourselves, controlling our world. Psychology's role in understanding positive and negative consequences of seeking and gaining control. Am Psychol, 51, 1213–1230.
Smith, K. R., West, J. A., Croyle, R. T., & Botkin, J. R. (1999). Familial context of genetic testing for cancer susceptibility: Moderating effects of siblings' test result on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol Biomarkers Prev, 8, 385–392.
Tercyak, K. P., Lerman, C., Peshkin, B., Hughes, C., Main, D., Isaacs, C., & Schwartz, M. D. (2001). Effects of copingstyle and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol, 20, 217– 222.
Thewes, B., Meiser, B., Tucker, K., & Schnieden, V. (2003). Screening for psychological distress and vulnerability factors in women at increased risk for breast cancer: A review of the literature. Psychol Health Med, 8, 289–304.
Van der Ploeg, H. M., Defares, P. B., & Spielberger, C. D. (1980). Handleiding bij de Zeflbeoordelingsvragenlijst: een Nederlandstalige bewerking van de Spielberger State-Trait Anxiety Inventory. Lisse: Swets & Zeitlinger.
Van Oostrom, I., Meijers-Heijboer, H., Lodder, L. N., Duivenvoorden, H. J., van Gool, A. R., Seynaeve, C., van der Meer, C. A., Klijn, J. G., van Geel, B. N., Burger, C. W., Wladimiroff, J. W., & Tibben, A. (2003). Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study. J Clin Oncol, 21, 3867–3874.
Wylie, J. E., Smith, K. R., & Botkin, J. R. (2003). Effects of spouses on distress experienced by BRCA1 mutation carriers over time. Am J Med Genet, 119C, 35–44.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Claes, E., Evers-Kiebooms, G., Denayer, L. et al. Predictive Genetic Testing for Hereditary Breast and Ovarian Cancer: Psychological Distress and Illness Representations 1 Year Following Disclosure. J Genet Counsel 14, 349–363 (2005). https://doi.org/10.1007/s10897-005-1371-4
Issue Date:
DOI: https://doi.org/10.1007/s10897-005-1371-4